Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
- PMID: 27746219
- DOI: 10.1016/j.matbio.2016.10.001
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
Abstract
Synthesis, deposition, and interactions of hyaluronan (HA) with its cellular receptor CD44 are crucial events that regulate the onset and progression of tumors. The intracellular signaling pathways initiated by HA interactions with CD44 leading to tumorigenic responses are complex. Moreover, HA molecules may perform dual functions depending on their concentration and size. Overexpression of variant isoforms of CD44 (CD44v) is most commonly linked to cancer progression, whereas their loss is associated with inhibition of tumor growth. In this review, we highlight that the regulation of HA synthases (HASes) by post-translational modifications, such as O-GlcNAcylation and ubiquitination, environmental factors and the action of microRNAs is important for HA synthesis and secretion in the tumor microenvironment. Moreover, we focus on the roles and interactions of CD44 with various proteins that reside extra- and intracellularly, as well as on cellular membranes with particular reference to the CD44-HA axis in cancer stem cell functions, and the importance of CD44/CD44v6 targeting to inhibit tumorigenesis.
Keywords: CD44; Cancer; Cancer stem cells; Hyaluronan; Hyaluronan synthase; Tissue-specific-targeting.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.Int J Mol Sci. 2017 Aug 24;18(9):1849. doi: 10.3390/ijms18091849. Int J Mol Sci. 2017. PMID: 28837080 Free PMC article. Review.
-
Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.Oncotarget. 2017 Apr 18;8(16):26927-26940. doi: 10.18632/oncotarget.15879. Oncotarget. 2017. PMID: 28460475 Free PMC article.
-
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.Stem Cells Transl Med. 2015 Sep;4(9):1033-43. doi: 10.5966/sctm.2015-0048. Epub 2015 Jul 1. Stem Cells Transl Med. 2015. PMID: 26136504 Free PMC article. Review.
-
The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer.Int J Mol Sci. 2023 Oct 31;24(21):15812. doi: 10.3390/ijms242115812. Int J Mol Sci. 2023. PMID: 37958796 Free PMC article. Review.
-
Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression.Int J Mol Sci. 2016 Apr 7;17(4):517. doi: 10.3390/ijms17040517. Int J Mol Sci. 2016. PMID: 27070574 Free PMC article. Review.
Cited by
-
CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.Oncol Rep. 2021 Apr;45(4):7. doi: 10.3892/or.2021.7958. Epub 2021 Mar 2. Oncol Rep. 2021. PMID: 33649828 Free PMC article.
-
A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy.Int J Nanomedicine. 2021 Mar 23;16:2373-2388. doi: 10.2147/IJN.S299681. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33790555 Free PMC article.
-
Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells.Front Oncol. 2021 May 31;11:642940. doi: 10.3389/fonc.2021.642940. eCollection 2021. Front Oncol. 2021. PMID: 34136383 Free PMC article.
-
'Two-faces' of hyaluronan, a dynamic barometer of disease progression in tumor microenvironment.Discov Oncol. 2023 Jan 25;14(1):11. doi: 10.1007/s12672-023-00618-1. Discov Oncol. 2023. PMID: 36698043 Free PMC article. Review.
-
The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.Matrix Biol. 2019 May;78-79:201-218. doi: 10.1016/j.matbio.2018.05.007. Epub 2018 May 21. Matrix Biol. 2019. PMID: 29792915 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous